An orthotopic in vivo model of human pancreatic cancer

Surgery

Volumn 126, Issue 3, 1999, Pages 562-567

  Schwarz, R E ^a   McCarty, T M ^a   Peralta, E A ^a   Diamond, D J ^a   Ellenhorn, J D I ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GEMCITABINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER MODEL; CANCER SURVIVAL; CANCER TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; SCID MOUSE;

EID: 0032874771     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70099-1     Document Type: Article

References (32)

1. SH Landis T Murray S Bolden PA Wingo Cancer statistics Ca Cancer J Clin 48 1998 6 29
2. DB Evans JL Abbruzzese TA Rich Cancer of the pancreas 5th ed VT DeVita S Hellman SA Rosenberg Cancer: principles and practice of oncology 1997 Lippincott-Raven Philadelphia 1054 1086
3. VD Courtenay IE Smith MJ Peckham GG Steel In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft Nature 263 1976 771 772
4. FM Marincola BJ Drucker DY Siao The nude mouse as a model for the study of human pancreatic cancer J Surg Res 47 1989 520 529
5. T Moriai T Takeba I Makino Experimental study on multidisciplinary treatment of pancreatic cancer Int J Pancreatol 6 1990 161 179
6. S Imai Y Nio T Shiraishi In vivo inhibitory effect of anticancer agents on human pancreatic cancer xenografts transplanted in nude mice Anticancer Res 11 1991 657 664
7. RM Schultz RL Merriman SL Andis In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin Anticancer Res 15 1995 1135 1139
8. R Alisauskus GY Wong DV Gold Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer Cancer Res 55 1995 5743s 5748s
9. T Shichinohe N Senmaru K Furuuchi Suppression of pancreatic cancer by the dominant negative ras mutant, N116Y J Surg Res 66 1996 125 130
10. RL Merriman LW Hertel RM Schultz Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models Invest New Drugs 14 1996 243 247
11. D Evoy EA Hirschowitz HA Naama In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer J Surg Res 69 1997 226 231
12. A Kaiser H Herbst G Fisher Retinoic acid receptor beta regulates growth and differentiation in human pancreatic carcinoma cells Gastroenterology 113 1997 920 929
13. M Peiper M Nagoshi D Patel Human pancreatic cancer cells (MPanc-96) recognized by autologous tumor-infiltrating lymphocytes after in vitro as well as in vivo tumor expansion Int J Cancer 71 1997 993 999
14. ME Rosenfeld SM Vickers D Raben Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene Ann Surg 225 1997 609 618
15. T Tani A Lumme A Linnala Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane Am J Pathol 151 1997 1289 1302
16. RM Mohammad MC Dugan AN Mohamed Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents Pancreas 16 1998 19 25
17. Z An X Wang T Kubota A clinical nude mouse metastatic model for highly malignant human pancreatic cancer Anticancer Res 16 1996 627 631
18. L Yang R Hwang L Pandit Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir Ann Surg 224 1996 405 414
19. RM Mohammad A Al-Katib GR Pettit An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies Clin Cancer Res 4 1998 887 894
20. M Lieber J Mazzetta W Nelson-Rees Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas Int J Cancer 15 1975 741 747
21. Z Yu X Liu TM McCarty The use of transgenic mice to generate high affinity p53 specific cytolytic T cells J Surg Res 69 1997 337 343
22. TM McCarty Z Yu X Liu An HLA-restricted, p53 specific immune response from HLA transgenic p53 knockout mice Ann Surg Oncol 5 1998 93 99
23. DJ Diamond J York JY Sun Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection Blood 90 1997 1751 1767
24. EL Kaplan P Meier Nonparametric estimation from incomplete observations Am Stat Assoc J 53 1958 457 481
25. R Peto MC Pike Conservatism in the approximation E(0-E)2/E in the log rank test for survival data or tumor incidence data Biometrics 29 1973 579 584
26. RM Schultz RL Merriman JE Toth Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenografts Oncol Res 5 1993 223 228
27. TM McCarty X Liu JY Sun Targeting p53 for adoptive T-cell immunotherapy Cancer Res 58 1998 2601 2605
28. CA Staley JE Lee KR Cleary Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head Am J Surg 171 1996 118 124
29. IJ Fidler Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture Cancer Res 50 1990 6130 6138
30. R Radinsky IJ Fidler Regulation of tumor cell growth at organ-specific metastases In Vivo 6 1992 325 331
31. BU Pauli HG Augustin-Voss ME el-Sabban Organ-preference of metastasis: the role of endothelial cell adhesion molecules Cancer Metastasis Rev 9 1990 175 189
32. DZ Zhu CF Cheng BU Pauli Mediation of lung metastasis of murine melanomas by a lung-specific endothelial cell adhesion molecule Proc Natl Acad Sci USA 88 1991 9568 9572